Domenico Gabrielli Selected Research

Glucose (Dextrose)

3/2023	[Renal effects of sodium-glucose cotransporter 2 inhibitors in patients with cardiovascular disease with and without chronic kidney disease].
1/2023	Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes.
1/2023	[ANMCO practical guide for sodium-glucose cotransporter 2 inhibitor use in patients with heart failure].
10/2022	The Benefit of Sodium-Glucose Co-Transporter Inhibition in Heart Failure: The Role of the Kidney.
5/2022	ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation.
2/2022	Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis.
10/2021	[ANMCO Position paper: Double, triple or quadruple therapy for heart failure with reduced ejection fraction. Current evidence and new strategies].
8/2021	[ANMCO Position paper: Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in diabetic patients and for the treatment of heart failure patients with and without diabetes].
8/2021	ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes.
4/2021	[Sodium-glucose co-transporter 2 inhibitors: mechanisms of renal action. Implications for diabetes and heart failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Domenico Gabrielli Research Topics

Disease

33	Heart Failure 04/2024 - 07/2009
17	Atrial Fibrillation 01/2024 - 05/2012
16	Hemorrhage 01/2024 - 05/2018
13	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 08/2020
13	Acute Coronary Syndrome 01/2023 - 05/2018
10	Neoplasms (Cancer) 05/2024 - 01/2021
10	Myocardial Infarction 01/2024 - 11/2019
10	Thrombosis (Thrombus) 06/2023 - 05/2018
9	Stroke (Strokes) 01/2024 - 01/2020
9	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 05/2016
9	COVID-19 02/2022 - 08/2020
8	Chronic Renal Insufficiency 01/2024 - 01/2021
7	Atherosclerosis 01/2024 - 01/2020
6	Venous Thromboembolism 01/2024 - 11/2019
6	Type 2 Diabetes Mellitus (MODY) 04/2023 - 04/2021
5	Hypercholesterolemia 07/2023 - 01/2021
4	Cardiotoxicity 04/2024 - 01/2021
4	Myocarditis (Carditis) 05/2023 - 12/2020
4	Infections 05/2023 - 03/2020
3	Cardiomyopathies (Cardiomyopathy) 04/2024 - 02/2023
3	Thromboembolism 12/2023 - 12/2021
3	Coronary Disease (Coronary Heart Disease) 11/2023 - 03/2023
3	Dyslipidemias (Dyslipidemia) 08/2023 - 10/2020
3	Inflammation (Inflammations) 06/2023 - 01/2022
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2023 - 07/2015
3	Ventricular Tachycardia 05/2023 - 07/2015
2	Heart Valve Diseases (Valvular Heart Disease) 01/2024 - 03/2019
2	Hypertriglyceridemia 12/2023 - 07/2019
2	Fever (Fevers) 10/2023 - 04/2018
2	Cardiac Arrhythmias (Arrythmia) 05/2023 - 05/2023
2	Pulmonary Embolism 04/2023 - 08/2020
2	Left Ventricular Dysfunction 01/2023 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 06/2022
2	Peripheral Arterial Disease 12/2022 - 11/2019
2	Heart Diseases (Heart Disease) 10/2022 - 10/2019
2	Chest Pain (Chest Pains) 06/2022 - 04/2018
2	Thrombocytopenia (Thrombopenia) 02/2022 - 12/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2021 - 03/2020
2	Ulcer 03/2021 - 03/2020
1	Sarcopenia 04/2024
1	Second Primary Neoplasms (Neoplasms, Second) 04/2024

Drug/Important Bio-Agent (IBA)

17	AnticoagulantsIBA 05/2024 - 01/2019
10	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 04/2021
8	oxidized low density lipoproteinIBA 12/2023 - 07/2019
8	Sodium-Glucose Transport ProteinsIBA 05/2023 - 05/2022
6	LDL CholesterolIBA 05/2023 - 07/2019
6	LipidsIBA 03/2023 - 07/2019
6	SodiumIBA 10/2022 - 04/2021
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 05/2018
5	SymportersIBA 10/2022 - 08/2021
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 07/2019
4	dapagliflozinIBA 01/2023 - 08/2021
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 04/2021
4	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2022 - 10/2018
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020 - 05/2018
3	vericiguatIBA 04/2024 - 04/2023
3	Vitamin K FDA Link 12/2023 - 01/2020
3	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 06/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 12/2021
3	RivaroxabanIBA 12/2022 - 03/2020
3	empagliflozinIBA 05/2022 - 08/2021
3	VaccinesIBA 02/2022 - 12/2021
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
3	Enalapril FDA LinkGeneric 10/2021 - 10/2018
3	CholesterolIBA 04/2021 - 10/2020
2	CytokinesIBA 04/2024 - 01/2022
2	Lipoprotein(a)IBA 01/2024 - 12/2022
2	Uric Acid (Urate)IBA 06/2023 - 01/2022
2	AntibodiesIBA 02/2022 - 12/2021
2	ReninIBA 01/2022 - 04/2021
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 01/2019
2	Neprilysin (Neutral Endopeptidase)IBA 10/2021 - 10/2018
2	CanagliflozinIBA 08/2021 - 08/2021
2	ertugliflozinIBA 08/2021 - 08/2021
2	edoxabanIBA 03/2021 - 03/2020
2	Purinergic P2Y Receptor AntagonistsIBA 03/2021 - 03/2020
2	Dabigatran FDA Link 03/2021 - 03/2020
2	Proton Pump InhibitorsIBA 03/2021 - 03/2020
2	Warfarin (Coumadin)FDA LinkGeneric 03/2021 - 03/2020
2	SteroidsIBA 03/2021 - 03/2020
2	trans-crotonin (CTN)IBA 01/2021 - 01/2020
2	PCSK9 InhibitorsIBA 01/2020 - 07/2019
1	AnthracyclinesIBA 04/2024
1	ChemokinesIBA 04/2024
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 04/2024
1	ElectrolytesIBA 01/2024

Therapy/Procedure

43	Therapeutics 05/2024 - 07/2009
15	Percutaneous Coronary Intervention 01/2023 - 05/2018
8	Stents 05/2022 - 05/2018
4	Defibrillators (Defibrillator) 11/2023 - 07/2015
4	Secondary Prevention 01/2023 - 07/2019
3	Catheters 05/2023 - 01/2023
3	Heart-Assist Devices 05/2022 - 01/2022
2	Continuity of Patient Care 01/2023 - 10/2019
2	Heart Transplantation (Grafting, Heart) 05/2022 - 12/2020
2	Inappropriate Prescribing 05/2022 - 12/2021
2	Aftercare (After-Treatment) 10/2021 - 08/2021
1	Telerehabilitation 04/2024